Pharma news
Pharma
The US International Trade Commission (USITC) will investigate Regeneron Pharmaceuticals for the alleged infringement of a patent owned by its rival Novartis, it announced in a notice posted yesterday, July 21. 22 July 2020
Pharma
Gilead Sciences is continuing its expansion into the field of cancer therapeutics with the purchase of a 49.9% stake in California-based biotechnology company Tizona. 22 July 2020
Americas
3M has obtained a permanent injunction from an Ohio judge, as part of its settlement in a lawsuit filed against a company it accused of reselling N95 masks at “grossly inflated” prices amid the COVID-19 pandemic. 22 July 2020
Americas
AbbVie has used a “drip feed” of patents to secure more than nine years of extra exclusivity on blood cancer drug Imbruvica, a new report has revealed. 20 July 2020
Pharma
A US federal court has thrown out an appeal from Ono Pharmaceutical and a Nobel Prize-winning immunologist, in a dispute over who made groundbreaking discoveries in cancer therapy. 16 July 2020
Pharma
An attempt to obtain a supplementary protection certificate ended up raising the bar to achieving this coveted IP, as Joel Beevers and Michael Pears of Potter Clarkson explain. 10 July 2020
Pharma
The rush to open access to IP-protected tech, medicines and devices in the fight against COVID-19 could cause problems later, argues MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch. 10 July 2020
Pharma
US medical technology company CardioNet has lost an appeal at the US Court of Appeals for the Federal Circuit , which found its patents covered abstract concepts and therefore are invalid. 3 July 2020
Pharma
European law firm Carpmaels & Ransford has promoted Jennifer Antcliff to partner in its dispute resolution team in its London office, bringing the total number of partners in the team to five. 2 July 2020
Americas
Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel. 2 July 2020